ストックスクリーナーアプリを入手
94.65
0.68%
0.64
Astrazeneca PLC (AZN) 最新ニュース
Walmart joins Nasdaq 100 on January 20, replacing AstraZeneca - MSN
Walmart joins Nasdaq 100, $19 billion investment surge coming - Cryptopolitan
Walmart set to join Nasdaq 100 on January 20 as AstraZeneca drops out - Business Standard
Walmart To Join Nasdaq 100 on Jan. 20 as AstraZeneca Exits - Bloomberg.com
Walmart to replace Astrazeneca on Nasdaq-100 on Jan 20 - MarketScreener
Walmart to replace Astrazeneca on Nasdaq-100 - MarketScreener
Walmart Set to Enter Nasdaq 100 on January 20, Replacing AstraZeneca - Bitget
Can AstraZeneca PLC (ZEG) stock sustain institutional flowsJuly 2025 Chart Watch & Fast Entry High Yield Tips - ulpravda.ru
Astrazeneca (AZN) Stock Falls Amid Market Uptick: What Investors Need to Know - sharewise.com
Can AstraZeneca PLC (Common Stock) (ZEGA) stock sustain breakout momentumRisk Management & Real-Time Stock Price Movement Reports - ulpravda.ru
Pharmacy XD Launches Nationally Licensed Direct-to-Patient Mail Order Pharmacy and Distribution Platform - Benzinga
AstraZeneca Taps Rick Suarez as US President & Head of the US Biopharmaceuticals Business Unit - Contract Pharma
AstraZeneca names insider Rick Suarez as head of US biopharmaceuticals unit - Reuters
ASTRAZENECA : Gets a Buy rating from Berenberg - MarketScreener
AstraZeneca Appoints Rick R. Suarez As Senior Vice President, US President, And Head Of US BioPharmaceuticals Business Unit - MarketScreener
AstraZeneca names Rick Suarez as US president to lead $50 billion investment By Investing.com - Investing.com UK
Why AstraZeneca is putting $50B behind a new US boss - Stock Titan
AstraZeneca plc Announces Executive Changes , Effective March 1, 2026 - MarketScreener
Is It Too Late To Consider AstraZeneca (LSE:AZN) After A 35% One-Year Rally? - Yahoo Finance UK
AstraZeneca Bets Big On America With $50B Investment, New Virginia Hub Plans Amid Pharma Tariff Jitters - MSN
Will AstraZeneca PLC (Common Stock) (ZEGA) stock profit from AI boomShort Selling Opportunities & Affordable Market Trading - ulpravda.ru
BostonGene teams up with AstraZeneca on AI-driven oncology - The Pharma Letter
My time working with the manufacturer of the AstraZeneca drug substance - substack.com
BostonGene, AstraZeneca Partner to Advance Oncology Drug Development - Contract Pharma
Check out AstraZeneca PLC's stock price (AZN-GB) in real time - CNBC
Check out AstraZeneca PLC's stock price (AZN) in real time - CNBC
AstraZeneca PLC (AZN) Stock Analysis: A Healthcare Giant With 8% Upside Potential - DirectorsTalk Interviews
AstraZeneca stock hits all-time high at 94.02 USD - Investing.com
AstraZeneca stock hits all-time high at 94.02 USD By Investing.com - Investing.com South Africa
JP Morgan expects solid AstraZeneca quarter and reassuring outlook - Proactive financial news
AstraZeneca's (AZN) Saphnelo Shows Promising Phase III Results - GuruFocus
AstraZeneca's Self-Injectable Lupus Drug Shines In Late-Stage Trial - Benzinga
Astrazeneca Study Shows Saphnelo Injection Reduces Lupus Disease Activity - marketscreener.com
Eyes on Asia: Insilico, Ipsen, AstraZeneca - BioXconomy
AstraZeneca flags positive trial data for Saphnelo as SLE treatment - MarketScreener
Haleon Shares Added, AstraZeneca Removed From Goldman Sachs European Conviction List - AskTraders.com
AstraZeneca says Saphnelo SC showed significant reduction in lupus disease activity - marketscreener.com
J.P. Morgan Maintains ASTRAZENECA PLC(AZNCF.US) With Buy Rating, Raises Target Price to $212.79 - 富途牛牛
G-Protein Coupled Receptors (GPCRs) Market Size to Hit USD 6.04 Billion by 2032, Growing at a CAGR of 5.59% - GlobeNewswire Inc.
AstraZeneca (AZN) Dropped from Goldman Sachs' European Convictio - GuruFocus
AstraZeneca PLC $AZN Stake Boosted by Allspring Global Investments Holdings LLC - MarketBeat
The Truth About AstraZeneca plc: Why Everyone Is Suddenly Paying Attention - AD HOC NEWS
Can AstraZeneca PLC ZEG stock sustain institutional flowsMarket Weekly Review & Daily Stock Trend Reports - moha.gov.vn
Key facts: AstraZeneca lowers drug prices for Medicaid; reports share count - TradingView — Track All Markets
AstraZeneca reports total voting rights of 1.55 billion shares - Investing.com
AstraZeneca reports total voting rights of 1.55 billion shares By Investing.com - Investing.com South Africa
REGAstraZeneca PLCTotal Voting Rights - TradingView — Track All Markets
Biological Therapies for Cancer Global Markets Report 2025-2030: Merck, BMS, Roche, AstraZeneca, Johnson & Johnson, and Novartis Drive Growth Through Pipeline Expansion and Strategic CollaborationsResearchAndMarkets.com - FinancialContent
Q4 EPS Estimates for AstraZeneca Boosted by Zacks Research - MarketBeat
My Personal CFO LLC Acquires Shares of 38,411 AstraZeneca PLC $AZN - MarketBeat
Zacks Research Raises Earnings Estimates for AstraZeneca - MarketBeat
25,322 Shares in AstraZeneca PLC $AZN Purchased by Moody Lynn & Lieberson LLC - MarketBeat
AstraZeneca PLC (AZN) Secures EU Approval for Imfinzi - MSN
The Zacks Analyst Blog Highlights Berkshire Hathaway, AstraZeneca, Intel, Kingsway Financial and BK Technologies - Yahoo Finance
Smith Salley Wealth Management Raises Stock Holdings in AstraZeneca PLC $AZN - MarketBeat
Top Stock Reports for Berkshire Hathaway, AstraZeneca & Intel - Nasdaq
Ethic Inc. Acquires 11,638 Shares of AstraZeneca PLC $AZN - MarketBeat
Why AstraZeneca PLC (Common Stock) (ZEGA) stock appears on watchlistsHigh Frequency Trading Trends & Free Powerful Profit Generation - bollywoodhelpline.com
Valicenti Advisory Services Inc. Has $4.66 Million Holdings in AstraZeneca PLC $AZN - MarketBeat
DAVENPORT & Co LLC Increases Stake in AstraZeneca PLC $AZN - MarketBeat
AstraZeneca PLC (AZN) Stock Price Today - CoinMarketCap
AstraZeneca stock holds steady as mixed news and technicals limit major moves - Traders Union
大文字化:
|
ボリューム (24 時間):